Fireside Peptide Delivery Discussion – Pushing the Limits of Peptide Formulation & Delivery from Novel Design to Effective Targeting Strategies for Better Patient Outcomes

• How to effectively design patient-centric peptide delivery formulations (oral vs injectable)?
• How to ensure novel peptide formulations can be scalable and cost efficient during the manufacturing process?
• Where will delivery innovations take the peptide field in the next 5 years?

Speakers:

Maria Fawaz

Associate Principal Scientist, DMPK

Merck & Co

Annette Bak

Advanced Drug Delivery Head

AstraZeneca

Florian Foeger

Founder & Chief Executive Officer

Cyprumed

Thomas Von Erlach

Co-Founder & Chief Scientific Officer

Vivtex

David Brayden

Professor - Advanced Drug Delivery

University College Dublin

Sumit Arora

Senior Principal Scientist

Johnson & Johnson

Philip Jonas Sassene

Scientific Director

Novo Nordisk

Vincent Jannin

Head Director, Research Development & of Innovaform Accelerator

Lonza